http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007261976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
filingDate 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f24f504487c987f0b9b906bbf1d7ca3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387001b48315f4e92aa6bc2d335537a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd814240b4ead0ba476601aa0004270
publicationDate 2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007261976-A
titleOfInvention Method for producing antitumor anthracycline antibiotics
abstract 【Task】 Aiming to supply inexpensive products to the medical field by developing a simpler method for producing the antitumor anthracycline antibiotic epirubicin than ever before and providing an industrial and low-cost production method To do. [Solution] 4'-epidaunorubicin or a salt thereof is reacted with a brominating agent in the presence of a ketalizing agent to obtain a bromoketal compound, then treated with a ketone solvent under acidic conditions to obtain a bromoketone compound, and further a carboxylic acid A method for producing epirubicin, characterized in that epirubicin or a salt thereof is obtained by hydrolysis in the presence of a metal salt.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009035107-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301343-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107683284-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836465-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014515381-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836404-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836465-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180009737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836404-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020507608-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016159092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7159177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016159092-A1
priorityDate 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451030023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453374978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21966525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415825438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16154789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65348

Total number of triples: 53.